Events on 15 March 2022

Cervical Screening Programme
Chair: Alison Malkin
9.00 HPV Screening – Four Nations Update:
Wales: Louise Dunk, Public Health Wales
Scotland: Gillian Collins, NHS Greater Glasgow & Clyde, Queen Elizabeth Univeristy Hospital
Northern Ireland: Jackie Jamieson, Northern Health and Social Care Trust
England: Dr Karin Denton, Severn Pathology, North Bristol NHS Trust
10.30 Molecular Markers for Cervical Screening
Dr Cara Martin, Molecular Pathology Research Group, Trinity College Dublin
11.15 Laboratory Clinical Professional Group
Dr Karin Denton, Severn Pathology, North Bristol NHS Trust
12.45 Cervical Cytology interactive case presentations Peter Heptinstall, North of England Pathology & Screening Education Centre (NEPSEC)

Chair: Andrew Usher
9.00 New HCPC Standards of Proficiency: Changes, emphasis and impact Alan Wainwright, Executive Head of Education, IBMS
9.30 CPD – what can we learn from other professions?
Gary Strong, College of Paramedics
10.30 Band 6 – finding, keeping, developing Penny Feather,
Path Links Pathology
11.00 Challenges of delivering training with a limited scope service Dr Mairiead MacLennan, Victoria Hospital, Kirkcaldy
11.30 Embedding leadership – training people to lead?

Chair: Andrew Usher
9.00 New HCPC Standards of Proficiency: Changes, emphasis and impact Alan Wainwright, Executive Head of Education, IBMS
9.30 CPD – what can we learn from other professions?
Gary Strong, College of Paramedics
10.30 Band 6 – finding, keeping, developing Penny Feather,
Path Links Pathology
11.00 Challenges of delivering training with a limited scope service Dr Mairiead MacLennan, Victoria Hospital, Kirkcaldy
11.30 Embedding leadership – training people to lead?

Chair: Nikki Lawrence
Morphology
9.00 Morphology quiz Dr Michelle Brereton, Manchester University NHS Foundation Trust
10.30 The Integration of Morphology with Immunophenotyping and other modalities in haematological neoplasms
Prof. Barbara Bain, Imperial College NHS Healthcare Trust
Drugs and Technology
11.00 Immunodulatory drug resistance in myeloma
Dr Charlotte Pawlyn, The Institute of Cancer Research
11.30 Next-generation sequencing in myeloid neoplasms
Dr Srinivas Pillai, University Hospitals of North Midlands NHS Trust

Chair: Alison Cox
9.00 Hereditary angioedema
Dr Patrick Yong, Frimley Health NHS Foundation Trust
9.30 Allergy component refresher
Dr Graeme Wild, Sheffield Teaching Hospitals NHS Foundation Trust
10.30 Autoimmunity testing on a mutidisciplinary track Dipti Patel, North West London Pathology
11.00 Choosing wisely
– an immunology perspective
Chris Scott, East and South East London Pathology Partnership
11.30 Type 1 Interferon Regulation in SLE and its wider implications in autoimmune disease
Dr Antony Psarras, King’s College Hospital NHS Foundation Trust

13.50 Albert Norman Address
Allan Wilson, Past President, Institute of Biomedical Science
14.10 Turning a vision in to a reality
David Wells, Chief Executive, Institute of Biomedical Science
14.20 Equality of recognition: Access to HSST for biomedical scientists
Dr Lisa Ayers, HCS Health Education England Dean for the South West and Training Programme Director for HSST
14.40 The UK response to theCovid-19 pandemic – lessons learned
Professor Sir Jonathan Van-Tam, Deputy Chief Medical Officer
15.05 The UK response to the Covid-19 pandemic from a pathology perspective
Professor Jo Martin, National Specialty Advisor for Pathology NHS England and Improvement
16.00 The creation and launch of a Pathology Network Joanna Andrew, Network Lead for Blood Sciences Scarborough, Hull, York Pathology Service
16.20 Integrating molecular diagnostics across hospital pathology
Bruno Ping, Molecular Biologist, Cignpost Diagnostics
16.40 How much does your blood group control your life? Martin Maley, Senior Lecturer in Biomedical Sciences, University of Sunderland